Literature DB >> 2170050

Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via beta 1-adrenoceptor activation.

K Pettersson1, B Bejne, H Björk, W B Strawn, G Bondjers.   

Abstract

Sympathetic activation appears to accelerate the development of atherosclerosis, an effect that may be inhibited by beta-receptor blockade. It is unclear, however, which mechanisms mediate this effect. In view of the significance attached to endothelial injury in the initial phases of atherogenesis, we decided to test whether sympathetic activation might lead to an increase in endothelial injury. Chloralose anesthesia was used to induce sympathetic activation and the presence of intracellular IgG as a criterion of endothelial cell injury. The beta 1-selective beta-blocker metoprolol was used to evaluate if the effect(s) of sympathetic activation might be mediated by beta 1-adrenoceptors. In normal rabbits, the frequency of injured endothelial cells in unbranched areas of the thoracic aorta was 0.23%, compared with 1.93% in circumostial areas. Chloralose anesthesia caused significant increases in blood pressure, heart rate, and plasma norepinephrine, that is, caused sympathetic activation, and led to an approximately fivefold increase in the number of injured cells both in unbranched and in circumostial areas. This increase was totally inhibited by metoprolol pretreatment, indicating that it was mediated by beta 1-receptors. These observations suggest one possible mechanism that may connect sympathetic activation with atherogenesis and explain why beta-blockade protects against atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170050     DOI: 10.1161/01.res.67.4.1027

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  10 in total

1.  Endothelin activation of reactive oxygen species mediates stress-induced pressor response in Dahl salt-sensitive prehypertensive rats.

Authors:  Gerard D'Angelo; Analia S Loria; David M Pollock; Jennifer S Pollock
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

2.  The QT interval is associated with incident cardiovascular events: the MESA study.

Authors:  Roy Beinart; Yiyi Zhang; João A C Lima; David A Bluemke; Elsayed Z Soliman; Susan R Heckbert; Wendy S Post; Eliseo Guallar; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-11-10       Impact factor: 24.094

3.  Carotid plaque in Alzheimer caregivers and the role of sympathoadrenal arousal.

Authors:  Susan K Roepke; Elizabeth A Chattillion; Roland von Känel; Matthew Allison; Michael G Ziegler; Joel E Dimsdale; Paul J Mills; Thomas L Patterson; Sonia Ancoli-Israel; Susan Calleran; Alexandrea L Harmell; Igor Grant
Journal:  Psychosom Med       Date:  2011-01-07       Impact factor: 4.312

Review 4.  Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Authors:  G L Plosker; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 5.  Central sympathetic overactivity: maladies and mechanisms.

Authors:  James P Fisher; Colin N Young; Paul J Fadel
Journal:  Auton Neurosci       Date:  2009-03-06       Impact factor: 3.145

6.  Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits.

Authors:  D Vincze; A S Farkas; L Rudas; P Makra; N Csík; I Leprán; T Forster; M Csanády; J G Papp; A Varró; A Farkas
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

7.  Inhibition of platelet accumulation by beta 1-adrenoceptor blockade in the thoracic aorta of rabbits subjected to experimental sympathetic activation.

Authors:  K Pettersson; H Björk
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

8.  Accuracy of non-invasive stress testing in women and men with angina in the absence of obstructive coronary artery disease.

Authors:  Vedant S Pargaonkar; Yuhei Kobayashi; Takumi Kimura; Ingela Schnittger; Eric K H Chow; Victor F Froelicher; Ian S Rogers; David P Lee; William F Fearon; Alan C Yeung; Marcia L Stefanick; Jennifer A Tremmel
Journal:  Int J Cardiol       Date:  2018-10-23       Impact factor: 4.039

9.  β₁-Adrenoceptor stimulation suppresses endothelial IK(Ca)-channel hyperpolarization and associated dilatation in resistance arteries.

Authors:  P L Yarova; S V Smirnov; K A Dora; C J Garland
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 10.  Glia, sympathetic activity and cardiovascular disease.

Authors:  Nephtali Marina; Anja G Teschemacher; Sergey Kasparov; Alexander V Gourine
Journal:  Exp Physiol       Date:  2016-04-09       Impact factor: 2.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.